The lack of PD-L1 expression is found in about 25% of KRASmut patients and about 40% of KRASwt patients, while PD-L1 expression on ≥50% of tumor cells is found in about 40% of KRASmut patients compared to 20% of KRASwt patients. Here, CD274 is linked to neoplasm.